Cargando…

TPL2/COT/MAP3K8 (TPL2) Activation Promotes Androgen Depletion-Independent (ADI) Prostate Cancer Growth

BACKGROUND: Despite its initial positive response to hormone ablation therapy, prostate cancers invariably recur in more aggressive, treatment resistant forms. The lack of our understanding of underlying genetic alterations for the transition from androgen-dependent (AD) to ADI prostate cancer growt...

Descripción completa

Detalles Bibliográficos
Autores principales:	Jeong, Joseph H., Bhatia, Ayesha, Toth, Zsolt, Oh, Soohwan, Inn, Kyung-Soo, Liao, Chun-Peng, Roy-Burman, Pradip, Melamed, Jonathan, Coetzee, Gerhard A., Jung, Jae U.
Formato:	Texto
Lenguaje:	English
Publicado:	Public Library of Science 2011
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3022761/ https://www.ncbi.nlm.nih.gov/pubmed/21267413 http://dx.doi.org/10.1371/journal.pone.0016205

Ejemplares similares

Expression of the Tpl2/Cot oncogene in human T-cell neoplasias
por: Christoforidou, Anna V, et al.
Publicado: (2004)

Tumor Progression Locus 2 (Tpl2) Kinase as a Novel Therapeutic Target for Cancer: Double-Sided Effects of Tpl2 on Cancer
por: Lee, Hye Won, et al.
Publicado: (2015)

TPL2 kinase expression is regulated by the p38γ/p38δ-dependent association of aconitase-1 with TPL2 mRNA
por: Escós, Alejandra, et al.
Publicado: (2022)

Tamiz de problemas del lenguaje-TPL
por: Auza Benavides, Alejandra

TPL2 mediates IL-17R signaling in neuroinflammation
por: Xiao, Yichuan, et al.
Publicado: (2015)

Foot-and-Mouth Disease Virus Structural Protein VP1 Destroys the Stability of the TPL2 Trimer by Degradation of TPL2 To Evade Host Antiviral Immunity
por: Zhang, Keshan, et al.
Publicado: (2021)

MAP3K8 (TPL2/COT) Affects Obesity-Induced Adipose Tissue Inflammation without Systemic Effects in Humans and in Mice
por: Ballak, Dov B., et al.
Publicado: (2014)

MAP3K8/TPL-2/COT is a potential predictive marker for MEK inhibitor treatment in high-grade serous ovarian carcinomas
por: Gruosso, Tina, et al.
Publicado: (2015)

TPL2-NPM-p53 pathway monitors nucleolar stress
por: Eliopoulos, Aristides G., et al.
Publicado: (2015)

TPL-2 restricts Ccl24-dependent immunity to Heligmosomoides polygyrus
por: Kannan, Yashaswini, et al.
Publicado: (2017)

Cot/tpl2-MKK1/2-Erk1/2 controls mTORC1-mediated mRNA translation in Toll-like receptor–activated macrophages
por: López-Pelaéz, Marta, et al.
Publicado: (2012)

SlTPL1 Silencing Induces Facultative Parthenocarpy in Tomato
por: He, Mi, et al.
Publicado: (2021)

Two TPL-Binding Motifs of ARF2 Are Involved in Repression of Auxin Responses
por: Choi, Hee-Seung, et al.
Publicado: (2018)

TPL‐2 kinase induces phagosome acidification to promote macrophage killing of bacteria
por: Breyer, Felix, et al.
Publicado: (2021)

TPL-2 negatively regulates interferon-β production in macrophages and myeloid dendritic cells
por: Kaiser, Frank, et al.
Publicado: (2009)

Altered Prostanoid Signaling Contributes to Increased Skin Tumorigenesis in Tpl2 Knockout Mice
por: DeCicco-Skinner, Kathleen L., et al.
Publicado: (2013)

Prognostic role of TPL2 in early-stage non-small cell lung cancer
por: Boldrini, Laura, et al.
Publicado: (2017)

Tpl2 is required for VEGF-A-stimulated signal transduction and endothelial cell function
por: Fearnley, Gareth W., et al.
Publicado: (2019)

Tumor Progression Locus 2 (TPL2) Regulates Obesity-Associated Inflammation and Insulin Resistance
por: Perfield, James W., et al.
Publicado: (2011)

Tumor progression locus 2 (TPL2) in tumor-promoting Inflammation, Tumorigenesis and Tumor Immunity
por: Njunge, Lucy Wanjiru, et al.
Publicado: (2020)

Tpl2 kinase regulates T cell interferon-γ production and host resistance to Toxoplasma gondii
por: Watford, Wendy T., et al.
Publicado: (2008)

Tpl2 Protects Against Fulminant Hepatitis Through Mobilization of Myeloid-Derived Suppressor Cells
por: Xu, Jing, et al.
Publicado: (2019)

TPL2 kinase activity regulates microglial inflammatory responses and promotes neurodegeneration in tauopathy mice
por: Wang, Yuanyuan, et al.
Publicado: (2023)

A central role of IKK2 and TPL2 in JNK activation and viral B-cell transformation
por: Voigt, Stefanie, et al.
Publicado: (2020)

TPL-2 Regulates Macrophage Lipid Metabolism and M2 Differentiation to Control T(H)2-Mediated Immunopathology
por: Kannan, Yashaswini, et al.
Publicado: (2016)

TPL2 mediates autoimmune inflammation through activation of the TAK1 axis of IL-17 signaling
por: Xiao, Yichuan, et al.
Publicado: (2014)

Inhibition of TPL2 by interferon-α suppresses bladder cancer through activation of PDE4D
por: Qiang, Zhe, et al.
Publicado: (2018)

Mycobacteria induce TPL-2 mediated IL-10 in IL-4-generated alternatively activated macrophages
por: Chatterjee, Soumya, et al.
Publicado: (2017)

Overexpression of TPL2 may be a predictor of good prognosis in patients with breast invasive ductal carcinoma
por: Yu, Qin, et al.
Publicado: (2023)

Tumor Progression Locus 2 (Tpl2) Deficiency Does Not Protect against Obesity-Induced Metabolic Disease
por: Lancaster, Graeme I., et al.
Publicado: (2012)

Activation of ERK1/2 by MOS and TPL2 leads to dasatinib resistance in chronic myeloid leukaemia cells
por: Tsubaki, Masanobu, et al.
Publicado: (2023)

Pharmacological Inhibition of TPL2/MAP3K8 Blocks Human Cytotoxic T Lymphocyte Effector Functions
por: Chowdhury, Fatema Z., et al.
Publicado: (2014)

Genetic and pharmacologic inhibition of Tpl2 kinase is protective in a mouse model of ventilator-induced lung injury
por: Kaniaris, Evangelos, et al.
Publicado: (2014)

Tpl2 Ablation Leads to Hypercytokinemia and Excessive Cellular Infiltration to the Lungs During Late Stages of Influenza Infection
por: Latha, Krishna, et al.
Publicado: (2021)

IKBKE-driven TPL2 and MEK1 phosphorylations sustain constitutive ERK1/2 activation in tumor cells
por: Göktuna, Serkan Ismail
Publicado: (2022)

Regulation of anthocyanin accumulation via MYB75/HAT1/TPL-mediated transcriptional repression
por: Zheng, Ting, et al.
Publicado: (2019)

Preparation, Properties and Therapeutic Effect of a TPL Nanoparticle Thermosensitive Gel for Intra-Articular Injection
por: Wang, Lijuan, et al.
Publicado: (2023)

NF-κB1 p105 suppresses lung tumorigenesis through the Tpl2 kinase but independently of its NF-κB function
por: Sun, Fan, et al.
Publicado: (2015)

A144 CHRONIC DSS LEADS TO ALTERED EXPRESSION OF IRAK4/TPL2 PATHWAYS IN UC-COLONIZED MICE
por: Hann, A, et al.
Publicado: (2022)

Loss of Tpl2 activates compensatory signaling and resistance to EGFR/MET dual inhibition in v-RAS transduced keratinocytes
por: Kelley, Mary B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_u8dirl9t3ucgsfp5u6lbi1r0t4